Showing results (1961-1970 of 2,011) with videos related to

Sort By:
Pageof 202
Journal of Minimally Invasive Gynecology|March 31, 2023
How to Manage Endometriosis in Adolescence: The Endometriosis Treatment Italian Club ApproachLucia Lazzeri, Karin Louise Andersson, Stefano Angioni, et al.
Blood|January 17, 2016
Diffuse large B-cell lymphoma patient-derived xenograft models capture the molecular and biological heterogeneity of the diseaseBjoern Chapuy, Hongwei Cheng, Akira Watahiki, et al.
Archives of Gynecology and Obstetrics|October 8, 2021
Impact of endometriosis on obstetric outcome after natural conception: a multicenter Italian studyN Berlanda, W Alio, S Angioni, et al.
Clinical Chemistry|October 20, 2019
Multicenter Evaluation of Circulating Cell-Free DNA Extraction and Downstream Analyses for the Development of Standardized (Pre)analytical Work FlowsRita Lampignano, Martin H D Neumann, Sabrina Weber, et al.
Leukemia|November 20, 2024
Graft-versus-host disease after anti-CD19 chimeric antigen receptor T-cell therapy following allogeneic hematopoietic cell transplantation: a transplant complications and paediatric diseases working parties joint EBMT studyGuillermo Ortí, Christophe Peczynski, William Boreland, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2018
Early postnatal behavioral, cellular, and molecular changes in models of Huntington disease are reversible by HDAC inhibitionFlorian A Siebzehnrübl, Kerstin A Raber, Yvonne K Urbach, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 8, 2025
Impaired CAMK4 Activity Limits Atherosclerosis and Reprograms MyelopoiesisAzuah L Gonzalez, Cristina M Youwakim, Brenda F Leake, et al.
Blood|March 22, 2022
GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in GermanyWolfgang A Bethge, Peter Martus, Michael Schmitt, et al.
Gut|June 28, 2020
Loss of hepatic Mboat7 leads to liver fibrosisVeera Raghavan Thangapandi, Oskar Knittelfelder, Mario Brosch, et al.
The Lancet. Haematology|March 6, 2026
Venetoclax plus high-dose cytarabine and mitoxantrone as salvage treatment for relapsed or refractory acute myeloid leukaemia (RELAX): a multicentre, single-arm, phase 1/2 trialLeo Ruhnke, Christoph Schliemann, Jan-Henrik Mikesch, et al.
Pageof 202